Alzheimer's disease (AD) pathology is characterized by abnormal aggregation of the proteins amyloid-β (Aβ) and hyperphosphorylated tau accompanied by brain inflammation in the form of microglial activation [1, 2]. Here, MAPT is linked to Alzheimer disease.